Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Functional characterization of the biogenic amine transporters on human macrophages
Phillip M. Mackie, … , Michael S. Okun, Habibeh Khoshbouei
Phillip M. Mackie, … , Michael S. Okun, Habibeh Khoshbouei
Published January 11, 2022
Citation Information: JCI Insight. 2022;7(4):e151892. https://doi.org/10.1172/jci.insight.151892.
View: Text | PDF
Research Article Inflammation Neuroscience

Functional characterization of the biogenic amine transporters on human macrophages

  • Text
  • PDF
Abstract

Monocyte-derived macrophages (MDMs) are key players in tissue homeostasis and diseases regulated by a variety of signaling molecules. Recent literature has highlighted the ability for biogenic amines to regulate macrophage functions, but the mechanisms governing biogenic amine signaling in and around immune cells remain nebulous. In the CNS, biogenic amine transporters are regarded as the master regulators of neurotransmitter signaling. While we and others have shown that macrophages express these transporters, relatively little is known of their function in these cells. To address these knowledge gaps, we investigated the function of norepinephrine transporter (NET) and dopamine transporter (DAT) on human MDMs. We found that both NET and DAT are present and can uptake substrate from the extracellular space at baseline. Not only was DAT expressed in cultured MDMs, but it was also detected in a subset of intestinal macrophages in situ. Surprisingly, we discovered a NET-independent, DAT-mediated immunomodulatory mechanism in response to LPS. LPS induced reverse transport of dopamine through DAT, engaging an autocrine/paracrine signaling loop that regulated the macrophage response. Removing this signaling loop enhanced the proinflammatory response to LPS. Our data introduce a potential role for DAT in the regulation of innate immunity.

Authors

Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei

×

Figure 5

Inhibition of DAT enhances the proinflammatory program in response to LPS.

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of DAT enhances the proinflammatory program in response to LP...
(A) Cultured human macrophages were treated with vehicle, nomifensine, LPS, or LPS + nomifensine in the presence of NET/SERT blockade. LPS treatment significantly increased the secretion of all 3 soluble factors (IL-6, P = 0.02; TNF-α, P = 0.004; CCL2, P = 0.002). Nomifensine in the presence of LPS significantly increased the LPS-induced secretion of TNF-α (P = 0.003) and IL-6 (P = 0.02) and had a similar effect on CCL2 secretion. Data are from n = 12 experiments/group, and statistics were performed using a 1-way ANOVA with Tukey’s post hoc test. (B) Representative 40× images of cultured human macrophages treated with vehicle (media), LPS, or LPS + nomifensine and incubated with fluorescent latex beads, fixed, and labeled for IBA1. (C) The average integrated fluorescence intensity of phagocytic beads within macrophages showed a slight increase in LPS and a nonsignificant decrease with LPS + nomifensine. (D) Frequency histograms showing the skewed distribution of fluorescence intensity of phagocytic beads in macrophages across the 3 conditions. (E) Empiric cumulative frequency distribution curves of unstimulated, LPS-stimulated, and LPS + nomifensine–treated macrophages shows that LPS significantly increased phagocytosis compared with unstimulated condition (D-statistic = 0.1786, P < 0.0001). Cotreatment with LPS and nomifensine decreased macrophage phagocytosis back toward unstimulated levels (D-statistic = 0.1217, P < 0.0001, versus LPS-stimulated). Images and data in B–E are from n = 972–1510 cells/group across 3 independent experiments. Statistics were performed using Kolmogorov-Smirnov tests. (F) Representative images of cultured human macrophages treated as in A and incubated with MitoSox Red. (G) Only cotreatment with LPS + nomifensine produced a significant increase in mitochondrial superoxide levels compared with vehicle (P = 0.02). Images and data in (F and G) are from n = 12–13 experiments/group. Statistics were performed using a Kruskal-Wallis test with Dunn’s test for multiple comparisons.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts